NCT07158164 2025-11-13DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentRutgers, The State University of New JerseyPhase 4 Recruiting100 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled
NCT01047007 2023-09-21A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005Merck Sharp & Dohme LLCPhase 1 Terminated11 enrolled 10 charts
NCT00413322 2015-07-08Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsValerio TherapeuticsPhase 1 Completed35 enrolled
NCT00002951 2013-09-05Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck CancerUniversity of ChicagoPhase 2 Completed53 enrolled
NCT00054977 2012-03-12Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid TumorsGalectin Therapeutics Inc.Phase 1 Completed40 enrolled